Patent classifications
A61K31/4164
Glucono delta-lactone for treatment of vaginal fungal infections
The present invention relates to a pharmaceutical formulation for vaginal administration, wherein the formulation comprises a pharmaceutical acceptable excipient and glucono δ-lactone, wherein the glucono δ-lactone is present in an amount of 5 to 99 wt % of the formulation. The invention also relates to a pharmaceutical formulation according to the invention for use in the prevention or treatment of a urogenital fungal infection. Furthermore, the invention relates to glucono δ-lactone (formula (III)), for use in the in the prevention or treatment of a fungal infection.
Formulations of Enzalutamide
This disclosure provides formulations of enzalutamide and their use for treating hyperproliferative disorders.
Formulations of Enzalutamide
This disclosure provides formulations of enzalutamide and their use for treating hyperproliferative disorders.
LIVER X RECEPTOR (LXR) MODULATORS
Described herein are liver X receptor (LXR) modulators and methods of utilizing LXR modulators in the treatment of LXR-associated diseases, disorders or conditions. Also described herein are pharmaceutical compositions containg such compounds.
Combination of bactericidal agent with a lysosomotropic alkalinising agent for the treatment of a bacterial infection
The present invention relates to the field of medicine, specifically the field of bacterial infection and treatment thereof.
Combination of bactericidal agent with a lysosomotropic alkalinising agent for the treatment of a bacterial infection
The present invention relates to the field of medicine, specifically the field of bacterial infection and treatment thereof.
Skin Protectant Paste
An article of manufacture for providing a skin protective paste is disclosed.
Skin Protectant Paste
An article of manufacture for providing a skin protective paste is disclosed.
Pharmaceutical cream compositions of oxymetazoline and methods of use
The present invention is directed to: a) a method of treating telangiectasia; b) a method of treating inflammatory lesions; and c) a method of treating two or more symptoms of rosacea selected from erythema, telangiectasia, or inflammatory lesions comprising topical administration of a pharmaceutical composition comprising oxymetazoline and a pharmaceutically acceptable excipient.
Pharmaceutical cream compositions of oxymetazoline and methods of use
The present invention is directed to: a) a method of treating telangiectasia; b) a method of treating inflammatory lesions; and c) a method of treating two or more symptoms of rosacea selected from erythema, telangiectasia, or inflammatory lesions comprising topical administration of a pharmaceutical composition comprising oxymetazoline and a pharmaceutically acceptable excipient.